From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Tern – Offer Fails, Leith Sells (Naughty), Cash Running Out And What About The Audit?

By Nigel Somerville | Tuesday 24 September 2024


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Oh Dear, oh dear, oh dear. Oh dearie me. What a total fiasco AIM-listed Tern plc (TERN) is…..told y’all. Even as recently as five days ago I suggested that Tern was in trouble as the latest attempt to hawk cash would fail. Well, it has: Tern has days to go before it runs out of cash, Bruce Leith (a former director until just over a year ago and still a PMDR) seems to me to have been selling shares unannounced and the auditors, having signed this POS off as a Going Concern only in May…..they should be shot: what happened to professional scepticism; what happened to making sure the numbers (you only had one job…!) added up?
Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 12:21:57